With the publication of the long-term data from the RELAZA2 study, a research program developed over many years by Dresden ...

Bay Area children with blood disorders could get faster access to clinical trials and emerging treatments through a new ...

A team of researchers found a potential new target for treating diseases associated with human T-cell leukemia virus type 1, including a specific type of leukemia and a neuroinflammatory disease ...

Treatment with so-called BTK inhibitors has improved the prognosis for people with chronic lymphocytic leukemia (CLL). At the same time, these drugs affect the immune system and may cause side effects ...

Why minimal residual disease testing is the "gold standard" for some patients and providers. When Michael Ray went to his doctor for an annual checkup two years ago, he felt fine. But the bloodwork ...

Ten years after its first FDA approval, Amgen’s Blincyto continues to make inroads in treating acute lymphoblastic leukemia. Now, the drug has delivered a phase 3 win that further demonstrates its ...

A hidden structure inside the cell is rewriting how scientists understand leukemia. Beneath the microscope, what looked like disorder turned out to follow a simple physical rule – one that connects ...

Leukemia and lupus are both conditions that affect the immune system. Although they are different, they share certain symptoms. A person with lupus may have increased risk of developing leukemia.

Carlo Acutis, the first Roman Catholic saint of the millennial generation, was in the right place at the wrong time. Carlo Acutis When he developed the rare, aggressive blood cancer called acute ...

At the end of 2021, Johanna Mendoza, then 22, was in Mexico on vacation when she developed little red dots on her wrist. “I thought maybe I just ate something that was no good for my body,” the ...